Paper Details
- Home
- Paper Details
Original Abstract of the Article :
BACKGROUND: Opioid-induced constipation is commonly seen in pediatrics, especially at the end of life. As patients clinically decline, constipation often leads to increased pain and distress, while its enteral treatment becomes more challenging. METHOD: There is little information about the safety ...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822361/
データ提供:米国国立医学図書館(NLM)
Methylnaltrexone: A Hope for Opioid-Induced Constipation in Pediatrics
This case report presents a compelling story of a 17-month-old girl battling leukemia and facing the debilitating challenges of opioid-induced constipation. The authors successfully treated the child's severe constipation and rectal prolapse with methylnaltrexone, a μ-opioid-receptor antagonist. This report highlights the potential of methylnaltrexone as a treatment option for opioid-induced constipation in children, especially at the end of life. The case underscores the need for further research to establish safe and effective dosing guidelines for pediatric patients.
Methylnaltrexone: A Potential Solution for Opioid-Induced Constipation in Children
This case report demonstrates the potential of methylnaltrexone in addressing opioid-induced constipation in pediatric patients, especially in cases of advanced cancer. The successful use of methylnaltrexone in this young patient provides encouraging evidence for further research and exploration of this medication's potential in pediatric care.
Opioid-Induced Constipation in Children: Navigating a Delicate Terrain
This case report sheds light on the challenges of managing opioid-induced constipation in children, a complex terrain that requires careful navigation. The report underscores the need for effective and safe treatment options for these vulnerable patients. It's like finding a safe oasis in a vast desert, offering relief and respite from the discomfort of constipation.
Dr.Camel's Conclusion
This case report provides a glimpse of hope for managing opioid-induced constipation in children, particularly in cases of advanced disease. The successful use of methylnaltrexone in this young patient highlights its potential benefits and the need for further research to establish safe and effective dosing guidelines for pediatric patients. It's a reminder that even in the harshest deserts of illness, there can be moments of respite and relief, offering hope and a chance for healing.
Date :
- Date Completed 2014-07-09
- Date Revised 2021-10-21
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.